IMA vs GILD: Which Stock is Better?
Side-by-side comparison of Imagenebio Inc and Gilead Sciences Inc in 2026
IMA
Imagenebio Inc
$4.90
GILD
Gilead Sciences Inc
$140.45
Key Metrics Comparison
| Metric | IMA | GILD | Winner |
|---|---|---|---|
| Market Cap | $54.83M | $172.56B | GILD |
| P/E Ratio | N/A | 20.51 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 100.0% | 78.8% | IMA |
Analyze IMA
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMA or GILD a better investment?
Comparing IMA and GILD: Imagenebio Inc has a market cap of $54.83M while Gilead Sciences Inc has $172.56B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMA and GILD?
IMA (Imagenebio Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMA or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMA or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for IMA.
Which company is more profitable: IMA or GILD?
Imagenebio Inc (IMA) has higher gross margins at 100.0% compared to 78.8% for GILD.
Which is the larger company: IMA or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $172.56B compared to $54.83M for IMA.
Should I buy IMA or GILD in 2026?
Both IMA and GILD have investment merit. IMA trades at $4.90 while GILD trades at $140.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMA and GILD stock?
Key differences: Market Cap ($54.83M vs $172.56B), P/E Ratio (N/A vs 20.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (100.0% vs 78.8%).